Ipsen Sells Shares In PregLem Holding SA to Gedeon Richter Plc
11 Octubre 2010 - 1:07AM
Noticias Dow Jones
French pharmaceutical group Ipsen SA (IPN.FR) Monday said it
sold its shares in in PregLem Holding SA to Gedeon Richter Plc
(RICHTER.BU0, as have all PregLem's other shareholders.
MAIN FACTS:
- Ipsen will receive initial proceeds of CHF 6 million from the
sale of its PregLem shares. Ipsen may also receive progressive
additional payments of up to CHF 25 million, contingent upon the
achievement of certain business development and regulatory
milestones for EsmyaTM.
- The impact of this transaction will be recorded as financial
income in Ipsen's accounts.
- In June 2007, the Group spun off to PregLem, then a
newly-formed, privately held Swiss biopharmaceutical company, a
sulfatase inhibitor and a somatostatin analogue (PGL1001 and
PGL2001, respectively), patents and know-how for use in the field
of human reproductive medicine.
-In parallel, Ipsen subscribed to newly issued shares of
Preglem, representing a c.15 % minority interest in its share
capital.
- Additionally, subject to PGL1001 and PGL2001 being granted
marketing approvals, Ipsen will notably receive mid single digit
royalties on PregLem's future net sales of these products.
Company Web site: www.ipsen.com
- By Paris Bureau, Dow Jones Newswires; +331-4017-1740;
geraldine.amiel@dowjones.com;
Ipsen (PK) (USOTC:IPSEY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Ipsen (PK) (USOTC:IPSEY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Ipsen SA (PK) (OTCMarkets): 0 recent articles
Más de Ipsen S.A. ADS Artículos de Noticias